Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Pfizer, Karo Bio AB team up in the area of autoimmune disorders

Executive Summary

Pfizer Inc. has partnered with Karo Bio AB (nuclear receptor therapeutic protein targets) for the discovery and development of small-molecule retinoic acid-related orphan receptor (ROR-gamma) modulators for autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, and psoriasis.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies